Serum levels of interleukin-18 (IL-18), interleukin-1β (IL-1β), its soluble receptor sIL-1RII and C-reactive protein (CRP) in patients with Lyme arthritis

Infection

Volumn 34, Issue 3, 2006, Pages 158-162

  Pietruczuk, A ^a,b   Swierzbinska R ^c   Pancewicz, S ^c   Pietruczuk, M ^b   Hermanowska Szpakowicz, T ^c  

^a Regional Hospital ^*  (Poland)

^b Regional Hospital   (Poland)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 1BETA; SOLUBLE INTERLEUKIN 1 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD LEVEL; BORRELIA BURGDORFERI; BORRELIA INFECTION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYME DISEASE; MALE; SERUM;

ADULT; AGED; ARTHRITIS, INFECTIOUS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-18; LYME DISEASE; MALE; MIDDLE AGED;

EID: 33745569752     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-006-5013-z     Document Type: Article

References (36)

1. Nadelman RB, Wormser GP: Lyme borreliosis. Lancet 1998; 352: 557-565.
2. Steere AC: Lyme disease. N Engl J Med 2001; 345: 115-125.
3. Steere AC, Schoen RT, Taylor E: The clinical evolution of lyme arthritis. Ann Intern Med 1987; 107: 725-731.
4. Huppertz HI, Böhme M, Standaert SM, Karch H, Plotkin SA: Incidence of lyme borreliosis in the Würzburg Region of Germany. Eur J Clin Microbiol Infect Dis 1999; 18: 697-703.
5. Johnston YE, Duray PH, Steere AC, Kashgarian M, Buza J, Malawista SE, Askenase PW: Lyme arthritis. Spirochetes found in synovial microangiopathic lesions. Am J Pathol 1985; 118: 26-34.
6. Schmidli J, Hunziker T, Moesli P, Schaad UB: Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to lyme borreliosis. J Infect Dis 1988; 158: 905-906.
7. Snydman DR, Schenkein DP, Berardi VP, Lastavica CC, Pariser KM: Borrelia burgdorferi in joint fluid in chronic lyme arthritis. Ann Intern Med 1986; 104: 798-800.
8. Ebnet K, Brown KD, Siebenlist UK, Simon MM, Shaw S: Borrelia burgdorferi activates nuclear factor-kB and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol 1997; 158: 3285-3292.
9. Pietruczuk A, Zajkowska JM, Hermanowska-Szpakowicz T: Proinflammatory cytokines in humoral immune response. Pol Merkuriusz Lek 2001; 11: 434-437.
10. Wooten RM, Modur VR, McIntyre TM, Weis JJ: Borrelia burgdorferi outer membrane protein a induces nuclear translocation of nuclear factor-kB and inflammatory activation in human endothelial cells. J Immunol 1996; 157: 4584-4590.
11. Kondrusik M, Świerzbińska R, Zajkowska JM, Pancewicz SA, Grygorczuk S, Hermanowska-Szpakowicz T: Effect of antibiotic therapy on levels of proinflammatory cytokines: interleukin IL-1, IL-6 and tumor necrosis factor TNF-α in serum of patients with Lyme borreliosis. Wiad Lek 2002; 55: 276-281.
12. Grygorczuk S, Pancewicz S, Zajkowska J, Kondrusik M, Ś wierzbińska R, Hermanowska-Szpakowicz T: Concentrations of macrophage inflammatory proteins MIP-1alpha and MIP-1beta and interleukin 8 (IL-8) in Lyme borreliosis. Infection 2004; 32: 350-355.
13. Habicht GS, Katona LI, Benach JL: Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces Glioma cells to secrete Interleukin-6. J Infect Dis 1991; 164: 568-574.
14. Radolf JD, Norgard MV, Brandt ME, Isaacs RD, Thompson PA, Beutler B: Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct. J Immunol 1991; 147: 1968-1974.
15. Radolf JD, Arndt LL, Akins DR, Curetty LL, Levi ME, Shen Y, Davis LS, Norgard MV: Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol 1995; 154: 2866-2877.
16. Olee T, Hashimoto S, Quach J, Lotz M: IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol 1999; 162: 1096-1100.
17. Udagawa N, Norwood NJ, Elliott J, Mackay A, Owens J, Okamura H, Kurimoto M, Chambers TJ, Martin TJ, Gillespie MT: Interleukin-18 (interferon-gamma- inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J Exp Med 1997; 185: 1005-1012.
18. Nakanashi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001; 12: 53-72.
19. Nakanashi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423-474.
20. Shackelford R, Adams DO, Johnson SP: IFN-gamma and lipopolysaccharide induce DNA binding of transcription factor PU.1 in murine tissue macrophages. J Immunol 1995; 154: 1374-1382.
21. Wu CY, Maeda H, Contursi C, Ozato K, Seder RA: Differential requirement of IFN consensus sequence binding protein for the production of IL-12 and induction of Th1-type cells in response to IFN-gamma. J Immunol 1999; 162: 807-812.
22. Keane-Myers A, Nickell SP: Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 1995; 155: 2020-2028.
23. Matyniak JE, Reiner SL: T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med 1995; 181: 1251-1254.
24. Gross DM, Steere AC, Huber BT: T Helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol 1998; 160: 1022-1028.
25. Kalish RA, Leong JM, Steere AC: Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 1993; 61: 2774-2779.
26. Steere AC, Baxter-Lowe LA: Association of chronic, treatment-resistant Lyme arthritis with rheumatoid arthritis (RA) alleles. Arthritis Rheum 1998; 41: S81.
27. Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA: Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998; 281: 703-706.
28. Bazan JF, Timans JC, Kastelein RA: A newly defined interleukin-1? Nature 1996; 379: 591.
29. Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, Greer MR, Kennedy K, Carter R, Wei XQ, Xu D, Field M, Foulis A, Liew FY, McInnes IB: A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999; 104: 1393-1401.
30. Barthold SW, Persing DH, Armstrong AL, Peeples RA: Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am J Pathol 1991; 139: 263-273.
31. Åsbrink E, Hovmark A: Comments on the course and classification of Lyme borreliosis. Scand J Infect Dis 1991; 77(Suppl): 41-43.
32. Steere AC, Levin RE, Molloy PJ, Kalish RA, Abraham JH, Liu NY, Schmid CH: Treat ment of Lyme arthritis. Arthritis Rheum 1994; 37: 878-888.
33. Gondolf KB, Mihatsch M, Curschellas E, Dunn JJ, Batsford SR: Induction of experimental allergic arthritis with outer surface proteins of Borrelia burgdorferi. Arthritis Rheum 1994; 37: 1070-1077.
34. Orlando S, Matteucci C, Fadlon EJ, Buurman WA, Bardella MT, Colotta F, Introna M, Mantovani A: TNF-α, unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 Type II decoy receptor in human myelomonocytic cells. J Immunol 1997; 158: 3861-3868.
35. Gross DM, Huber BT: Cellular and molecular aspects of Lyme arthritis. Cell Mol Life Sci 2000; 57: 1562-1569.
36. Kalish RA, Leong JM, Steere AC: Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect Immun 1995; 63: 2228-2235.